HongTonHuaMD

Physician

Dr. Hua is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Massachusetts General HospitalFellowship, Vascular Surgery, 2003 - 2005
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Surgery, 1996 - 2003
Keck School of Medicine of the University of Southern CaliforniaClass of 1996

The Vascutek AnacondaTM Stent Graft System Phase II IDE Study Start of enrollment: 2009 Apr 01
Completed
Not Applicable
Zenith TX2® Post-market Approval Study Start of enrollment: 2009 Jul 10
Completed
Not Applicable
Evaluation of the GORE TIGRIS Vascular Stent Start of enrollment: 2012 Apr 01
Completed
Not Applicable
Zenith® p-Branch® OTS Multicenter Study Start of enrollment: 2013 Jan 01
Completed
Not Applicable
Join now to see all

PubMed

4 citations
Surgical management of middle aortic syndrome in an adult
Hubert Y. Luu, Marisa E. Pulcrano, Hong Ton Hua
Journal of Vascular Surgery Cases and Innovative Techniques. 2020-03-01
13 citations
Long-term freedom from aneurysm-related mortality remains favorable after endovascular abdominal aortic aneurysm repair in a 15-year multicenter registry.
Nicole Rich, Lue-Yen Tucker, Steven Okuhn, Hong Hua, Bradley B. Hill
Journal of Vascular Surgery. 2017-06-01
81 citations
Type II endoleak with or without intervention after endovascular aortic aneurysm repair does not change aneurysm-related outcomes despite sac growth.
Joy Walker, Lue-Yen Tucker, Philip P. Goodney, Leah Candell, Hong Hua
Journal of Vascular Surgery. 2015-09-01

Impact of Sequencing Targeted Therapies with High-Dose Interleukin-2 Immunotherapy: An Analysis of Outcome and Survival of Patients with Metastatic Renal Cell Carcinoma from an on-Going Observational IL-2 Clinical Trial: PROCLAIM SMFebruary 1st, 2017